Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...

UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...

Shares of the healthcare giant are still down more than 30% year to date, after plunging as much as 53% at one point. Should ...

One year after UnitedHealthcare's CEO was shot and killed, the crisis in U.S. health care is intensifying — even for the ...

UnitedHealth Group announced on Tuesday that Scott Gottlieb, a former commissioner of the FDA, is joining its board of directors effective immediately, marking CEO Stephen Hemsley's latest effort to ...

Nov 18 (Reuters) - UnitedHealth Group (UNH.N), opens new tab said on Tuesday it had named former U.S. Food and Drug Administration commissioner Scott Gottlieb to its board, effective immediately.

UnitedHealth Group's UNH stock hasn’t received the post-earnings rally that investors may have hoped for, but the medical giant was able to provide subtle signs that its operations are stabilizing.

UnitedHealth beat EPS expectations and raised full-year guidance, signaling early signs of stabilization. Operating income fell 51% as rising medical costs and funding cuts continued to pressure ...

UnitedHealth has returned to better-than-expected growth after starting the year swamped by medical costs and then withdrawing its forecast for 2025. Leaders of the health care giant said Tuesday that ...